Real-time PCR: Detection of oestrogen receptor-alpha and -beta isoforms and variants in breast cancer

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 4147-4156

  Al Bader, Maie ^a   Al Saji, Shorooq ^a   Ford, Christopher H J ^a   Francis, Issam ^a   Al Ayadhy, Bushra ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Breast cancer; Oestrogen receptor; Real time PCR

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MEDULLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPERATURE; WILD TYPE;

BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE AMPLIFICATION; HUMANS; PARAFFIN EMBEDDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78650239330     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Ferlay J, Bray F, Pisani P and Parkin D: Breast Cancer. In: Cancer Incidence, Mortality and Prevalence Worldwide, volume VI. Lyon, France: IARC Press, 2004.
2. Erenburg I, Schachter B, Lopez R and Ossowski L: Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its re-expression: interference with estrogen-stimulated properties of malignant transformation. Mol Endocrinol 11: 2004-2015, 1997.
3. Hsiao WC, Cho WC, Lin PW, Lin SL, Lee WY and Young KC: Quantitative profile of estrogen receptor variants/isoforms in Taiwanese women with breast cancer. Eur J Surg Oncol 32: 492-497, 2006.
4. Matthews J and Gustafsson JA: Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 3: 281-292, 2003.
5. Gallacchi P, Schoumacher F, Eppenberger-Castori S, Von Landenberg EM, Kueng W, Eppenberger U and Mueller H: Increased expression of estrogen-receptor exon-5-deletion variant in relapse tissues of human breast cancer. Int J Cancer 79: 44-48, 1998. (Pubitemid 28157725)
6. Heldring N, Nilsson M, Buehrer B, Treuter E and Gustafsson JA: Identification of tamoxifen-induced co-regulator interaction surfaces within the ligand-binding domain of estrogen receptors. Mol Cell Biol 24: 3445-3459, 2004. (Pubitemid 38455439)
7. Fuqua SA, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW and McGuire WL: Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 51: 105-109, 1991.
8. McGuire WL, Chamness GC and Fuqua SA: Abnormal estrogen receptor in clinical breast cancer. J Steroid Biochem Mol Biol 43: 243-247, 1992.
9. Zhang QX, Borg A and Fuqua SA: An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Cancer Res 53: 5882-5884, 1993. (Pubitemid 24006154)
10. Daffada AA, Johnston SR, Smith IE, Detre S, King N and Dowsett M: Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res 55: 288-293, 1995.
11. Leygue ER, Watson PH and Murphy LC: Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst 88: 284-290, 1996.
12. Pfeffer U, Fecarotta E, Arena G, Forlani A and Vidali G: Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. J Steroid Biochem Mol Biol 56: 99-105, 1996.
13. Zhang QX, Hilsenbeck SG, Fuqua SA and Borg A: Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J Steroid Biochem Mol Biol 59: 251-260, 1996.
14. Desai AJ, Luqmani YA, Walters JE, Coope RC, Dagg B, Gomm JJ, Pace PE, Rees CN, Thirunavukkarasu V, Shousha S, Groome NP, Coombes R and Ali S: Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance. Br J Cancer 75: 1173-1184, 1997. (Pubitemid 27140030)
15. Huang A, Leygue ER, Snell L, Murphy LC and Watson PH: Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer. Am J Pathol 150: 1827-1833, 1997.
16. Murphy LC, Dotzlaw H, Leygue E, Douglas D, Coutts A and Watson PH: Estrogen receptor variants and mutations. J Steroid Biochem Mol Biol 62: 363-372, 1997.
17. Razandi M, Pedram A, Merchenthaler I, Greene GL and Levin ER: Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18: 2854-2865, 2004.
18. Kumar VL, Kumar S, Srivastava A and Kumar V: Observations on the presence of E domain variants of estrogen receptor-alpha in breast tumors. J Surg Oncol 94: 332-337, 2006.
19. Deroo BJ and Korach KS: Estrogen receptors and human disease. J Clin Invest 116: 561-570, 2006.
20. Herynk MH and Fuqua SA: Estrogen receptor mutations in human disease. Endocr Rev 25: 869-898, 2004.
21. Garcia Pedrero JM, Zuazua P, Martinez-Campa C, Lazo PS and Ramos S: The naturally occurring variant of estrogen receptor (ER) ERDeltaE7 suppresses estrogen-dependent transcriptional activation by both wild-type ERalpha and ERbeta. Endocrinology 144: 2967-2976, 2003.
22. Leygue E, Dotzlaw H, Watson PH and Murphy LC: Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res 59: 1175-1179, 1999.
23. Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM and Moore JT: Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res 59: 5425-5428, 1999.
24. Speirs V, Adams IP, Walton DS and Atkin SL: Identification of wild-type and exon 5 deletion variants of estrogen receptor beta in normal human mammary gland. J Clin Endocrinol Metab 85: 1601-1605, 2000.
25. Mann S, Laucirica R, Carlson N, Younes PS, Ali N, Younes A, Li Y and Younes M: Estrogen receptor beta expression in invasive breast cancer. Hum Pathol 32: 113-118, 2001.
26. Poola I, Clarke R, DeWitty R and Leffall LD: Functionally active estrogen receptor isoform profiles in the breast tumors of African-American women are different from the profiles in breast tumors of Caucasian women. Cancer 94: 615-623, 2002.
27. Tong D, Schuster E, Seifert M, Czerwenka K, Leodolte S and Zeillinger R: Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines. Breast Cancer Res Treat 71: 249-255, 2002.
28. Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson JA and Toi M: Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor. Cancer Res 62: 4849-4853, 2002.
29. Saunders PT, Millar MR, Williams K, Macpherson S, Bayne C, O'Sullivan C, Anderson TJ, Groome NP and Miller WR: Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsies. Br J Cancer 86: 250-256, 2002.
30. Shaw JA, Udokang K, Mosquera JM, Chauhan H, Jones JL and Walker RA: Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol 198: 450-457, 2002.
31. Girault I, Andrieu C, Tozlu S, Spyratos F, Bieche I and Lidereau R: Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma. Cancer Lett 215: 101-112, 2004.
32. Esslimani-Sahla M, Kramar A, Simony-Lafontaine J, Warner M, Gustafsson JA and Rochefort H: Increased estrogen receptor betacx expression during mammary carcinogenesis. Clin Cancer Res 11: 3170-3174, 2005.
33. Park BW, Kim KS, Heo MK, Yang WI, Kim SI, Kim JH, Kim GE and Lee KS: The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development. J Surg Oncol 93: 504-510, 2006.
34. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM and Willson TM: Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 247: 75-78, 1998.
35. Poola I, Fuqua SA, De Witty RL, Abraham J, Marshallack JJ and Liu A: Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbetal and ERbeta5: potential molecular targets for chemoprevention. Clin Cancer Res 11: 7579-7585, 2005.
36. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y and Muramatsu M: Molecular cloning and characterization of human estrogen receptor beta ex: a potential inhibitor of estrogen action in human. Nucleic Acids Res 26: 3505-3512, 1998.
37. Townson SM and O'Connell P: Identification of estrogen receptor alpha variants in breast tumors: implications for predicting response to hormonal therapies. J Surg Oncol 94: 271-273, 2006.
38. van Dijk MA, Hart AA and van't Veer LJ: Differences in estrogen receptor alpha variant messenger RNAs between normal human breast tissue and primary breast carcinomas. Cancer Res 60: 530-533, 2000.
39. Poola I and Speirs V: Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues. J Steroid Biochem Mol Biol 78: 459-469, 2001.
40. Murphy LC and Watson PH: Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer? Endocr Relat Cancer 13: 327-334, 2006.
41. Leygue E, Dotzlaw H, Watson PH and Murphy LC: Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues. Breast Cancer Res 2: 64-72, 2000.
42. Fuqua SA, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL and McGuire WL: Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 52: 483-486, 1992.
43. Omoto Y, Iwase H, Iwata H, Hara Y, Toyama T, Ando Y and Kobayashi S: Expression of estrogen receptor alpha exon 5 and 7 deletion variant in human breast cancers. Breast Cancer 7: 27-31, 2000.
44. Chaidarun SS and Alexander JM: A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression. Mol Endocrinol 12: 1355-1366, 1998.
45. Chi A, Chen X, Chirala M and Younes M: Differential expression of estrogen receptor beta isoforms in human breast cancer tissue. Anticancer Res 23: 211-216, 2003.
46. Speirs V, Carder PJ, Lane S, Dodwell D, Lansdown MR and Hanby AM: Oestrogen receptor beta: what it means for patients with breast cancer. Lancet Oncol 5: 174-181, 2004.
47. Skliris GP, Leygue E, Curtis-Snell L, Watson PH and Murphy LC: Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer 95: 616-626, 2006.
48. Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Eden P, Peterson C, Malmstrom P, Isola J, Borg A and Ferno M: Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma. Clin Cancer Res 13: 1987-1994, 2007.
49. Speirs V, Skliris GP, Burdall SE and Carder PJ: Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. J Clin Pathol 55: 371-374, 2002.